View Latest Medical and Pharma Bids and Tenders

Pharmaceutical Discount Agreements From February 1, 2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure

Rehabilitation Work On A Building Into A Health Center In The Commune Of Mauléon

Epa Saint Etienne: Rehabilitation Works Contract For A Building At 52 Rue Aristide Briand Et De La Paix In Saint-Etienne - Lots 4, 6 And 7.

Rehabilitation Work Operation Of The Former Ursulines Clinic In Troyes Into A University Professional Public Health Center Lot No. 1: Preparatory Asbestos Removal Work.

Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Vildagliptin (A10Bh02) Within The Framework Of A So-Called Open-House Model.

Conclusion Of Non-Exclusive Discount Agreements Pursuant To Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Paliperidone (N05Ax13) And The Trade Name Trevicta® As Part Of A So-Called Open-House Model.

Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ertugliflozin (A10Bk04) Within The Framework Of A So-Called Open-House Model.

Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Iron(Iii) Sodium Gluconate Complex (B03Ac07) Within The Framework Of A So-Called Open-House Model.

Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Brinzolamide And Brimonidine (S01Ec24) Within The Framework Of A So-Called Open-House Model.

24B30617 - CvO-Uni OL, Site E; Medical laboratory and office building; Geothermal response test drilling